MOREHOUSE CCRE PP2- METABOLIC SYNDROME WITHIN AN UNDERSERVED COMMUNITY

该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 中心，不一定是研究者的机构。 这项研究的目的有三个方面：1）评估“真实的世界”中的临床医生是否常规地建立代谢综合征（MetS）可以被诊断的必要记录，2）评估当前诊断标准在初级保健环境中用于诊断MetS的临床效用，和3）定义MetS在城市内的初级保健实践中的患病率，服务不足的少数民族社区假设：1）初级保健实践中的大多数医疗记录不包含诊断MetS所需的特定临床数据，2）MetS的患病率相应地根据诊断标准而变化，以及3）与美国的一般人群相比，MetS的患病率在服务不足的少数诊所人群中更高。具体目标：1）评估电子病历系统在多医生初级保健实践中诊断MetS的实用性。2)在门诊、大都市、主要是少数民族、多医生诊所中定义MetS诊断所需的各种临床参数。3)根据ATP III标准、国际糖尿病联合会（IDF）对MetS的新定义或ATP III标准的临床实践修改，在门诊、大城市、主要为少数民族服务的人群中确定MetS的患病率，多的本研究将提供反映“真实的”MetS在服务水平低下的社区的实践护理的数据，并建立基础进一步研究和设计干预措施，以提高初级保健医生早期诊断、干预和治疗代谢综合征的能力，作为降低这一高危人群心血管疾病发病率和死亡率的一种手段。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is three-fold: 1) to evaluate whether clinicians in the 'real world' routinely establish the necessary record in which the metabolic syndrome (MetS) could be diagnosed, 2) to assess the clinical utility of the current diagnostic criteria for the diagnosis of the MetS in the primary care setting, and 3) to define the prevalence of the MetS in a primary care practice within an urban, underserved, minority community. Hypothesis: 1) most medical records in primary care practice do not contain the specific clinical data that are necessary for making the diagnosis of the MetS, 2) the prevalence of MetS varies accordingly diagnostic criteria, and 3) compared to the general population in the United States, the prevalence of MetS is higher in an underserved, minority clinic population. Specific aims: 1) Assess the utility of the electronic medical record system for diagnosis of MetS in a multi-physician primary care practice. 2) Define various clinical parameters necessary for the diagnosis of the MetS in an ambulatory, metropolitan, predominately racial minority, multi-physician practice clinic. 3) Determine the prevalence of the MetS based on ATP III criteria, the new definition of MetS from the International Diabetes Federation (IDF), or a clinical practice modification of the ATP III criteria in an ambulatory, metropolitan, predominately minority-serving, multi-physician primary care practice clinic.The study will provide the data that reflect the 'real' practice care of MetS in the underserved community and set up the basis for further study and design of interventions that will enhance the capacity of primary care physicians to diagnose early, intervene, and treat the MetS as a means of reducing the morbidity and mortality of CVD in this high risk population.